116Concomitant to these initial safety studies, the efficacy of PTC 124 was tested in mouse models,...

14
- 116 -

Transcript of 116Concomitant to these initial safety studies, the efficacy of PTC 124 was tested in mouse models,...

Page 1: 116Concomitant to these initial safety studies, the efficacy of PTC 124 was tested in mouse models, including a model for cystic fibrosis harboring the CFTR-G542X stop codon mutation

- 116 -

Page 2: 116Concomitant to these initial safety studies, the efficacy of PTC 124 was tested in mouse models, including a model for cystic fibrosis harboring the CFTR-G542X stop codon mutation

- 117 -

Page 3: 116Concomitant to these initial safety studies, the efficacy of PTC 124 was tested in mouse models, including a model for cystic fibrosis harboring the CFTR-G542X stop codon mutation

- 118 -

Page 4: 116Concomitant to these initial safety studies, the efficacy of PTC 124 was tested in mouse models, including a model for cystic fibrosis harboring the CFTR-G542X stop codon mutation

- 119 -

Page 5: 116Concomitant to these initial safety studies, the efficacy of PTC 124 was tested in mouse models, including a model for cystic fibrosis harboring the CFTR-G542X stop codon mutation

- 120 -

Page 6: 116Concomitant to these initial safety studies, the efficacy of PTC 124 was tested in mouse models, including a model for cystic fibrosis harboring the CFTR-G542X stop codon mutation

- 121 -

Page 7: 116Concomitant to these initial safety studies, the efficacy of PTC 124 was tested in mouse models, including a model for cystic fibrosis harboring the CFTR-G542X stop codon mutation

- 122 -

Page 8: 116Concomitant to these initial safety studies, the efficacy of PTC 124 was tested in mouse models, including a model for cystic fibrosis harboring the CFTR-G542X stop codon mutation

- 123 -

Page 9: 116Concomitant to these initial safety studies, the efficacy of PTC 124 was tested in mouse models, including a model for cystic fibrosis harboring the CFTR-G542X stop codon mutation

- 124 -

Page 10: 116Concomitant to these initial safety studies, the efficacy of PTC 124 was tested in mouse models, including a model for cystic fibrosis harboring the CFTR-G542X stop codon mutation

- 125 -

Page 11: 116Concomitant to these initial safety studies, the efficacy of PTC 124 was tested in mouse models, including a model for cystic fibrosis harboring the CFTR-G542X stop codon mutation

- 126 -

Page 12: 116Concomitant to these initial safety studies, the efficacy of PTC 124 was tested in mouse models, including a model for cystic fibrosis harboring the CFTR-G542X stop codon mutation

- 127 -

Page 13: 116Concomitant to these initial safety studies, the efficacy of PTC 124 was tested in mouse models, including a model for cystic fibrosis harboring the CFTR-G542X stop codon mutation

- 128 -

Page 14: 116Concomitant to these initial safety studies, the efficacy of PTC 124 was tested in mouse models, including a model for cystic fibrosis harboring the CFTR-G542X stop codon mutation

- 129 -